---
title: "GEMPHARMATECH's net profit for the year 2024 is 116 million yuan, a year-on-year decrease of 27.14%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229894716.md"
description: "According to the Zhitong Finance APP, GEMPHARMATECH released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 687 million yuan, an increase of 10.38% compared to the same period last year; the net profit attributable to the owners of the parent company was 116 million yuan, a decrease of 27.14% compared to the same period last year"
datetime: "2025-02-27T10:23:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229894716.md)
  - [en](https://longbridge.com/en/news/229894716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229894716.md)
generator: "portal-rs"
---

# GEMPHARMATECH's net profit for the year 2024 is 116 million yuan, a year-on-year decrease of 27.14%

According to the Zhitong Finance APP, GEMPHARMATECH (688046.SH) released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 687 million yuan, an increase of 10.38% compared to the same period last year; the net profit attributable to the owners of the parent company was 116 million yuan, a decrease of 27.14% compared to the same period last year

### Related Stocks

- [688046.CN](https://longbridge.com/en/quote/688046.CN.md)

## Related News & Research

- [TECHNICALS-CBOT wheat may retest support at $7.54-3/4](https://longbridge.com/en/news/297752187.md)
- [XPENG Sales Up 4% in August](https://longbridge.com/en/news/297713940.md)
- [Xiaomi sets September 7 launch for 18 Fold foldable phone](https://longbridge.com/en/news/297748864.md)
- [11:44 ETKnowesis Awarded Five Year Contract to Support Awards Management for the Congressionally Directed Medical Research Programs](https://longbridge.com/en/news/297808327.md)
- [Niagen Bioscience management participates in Longevity Investors Conference panel](https://longbridge.com/en/news/297786920.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**